Have you been diagnosed with non-small cell lung cancer? Have you already been treated with an anti PDL-1 therapy and chemotherapy? If so, you may be able to take part in a research study looking to compare the safety and effectiveness of the investigational drug RMC-6236 to docetaxel.
We are looking for adults ages 18 and up who are interested in using digital tools, a smartphone app, and text messages to help them make positive changes in their eating, activity, and weight.
We're looking into whether a dietary supplement from fish oils can ease ongoing jaw and face pain. These oils have ingredients that help calm inflammation and aid healing. By comparing this supplement to a placebo, which is just an inactive oil, we aim to see if the supplement can relieve chronic jaw pain and learn how it affects the body.
We're exploring how students use AI tools, like ChatGPT, to help with schoolwork and how colleges are responding. We want to know how these tools help students, especially those that are first in their family to attend college, in subjects like science and math. We'll collect information from schools on the kinds of rules they are putting in place. This way, we can understand better how AI is helping students and how colleges can support everyone fairly.
The purpose is to see if a drug, remibrutinib 25 mg twice a day, is safe and effective in treatment of peanut, milk or egg allergy.
We are doing a new study to better understand the experiences and beliefs of parents with daughters who have or had early puberty .
The purpose of this study is to compare the usual treatment alone (chemoradiation and pembrolizumab followed by pembrolizumab) to using induction chemotherapy therapy with pembrolizumab before chemoradiation and pembrolizumab followed by pembrolizumab. The addition of providing induction therapy (carboplatin, paclitaxel, and pembrolizumab) prior to the usual chemoradiation and pembrolizumab therapy could shrink your cancer or prevent it from returning
The purpose of this research study is to understand the experiences of transgender and nonbinary young adults (TGNB-YA) with gender-affirming care (GAC). GAC includes services like puberty blockers, hormone therapy, and affirming surgeries, which can reduce distress and support wellbeing. At the same time, getting care can bring challenges, including wait times, financial stress, side effects, or discrimination. This study will explore both the challenges and supports that TGNB-YA encounter in their GAC journeys, with attention to differences across racial and ethnic backgrounds. Our goal is to identify resources that can make affirming care more supportive and accessible.
We're doing this study to learn if a new investigational treatment can help people with type 2 diabetes who may have too much of a stress hormone called cortisol in their body. Too much cortisol can make it harder to control blood sugar. This study will test if lowering cortisol helps people with diabetes feel better and manage their blood sugar more easily.
We're looking at two alcohol sensors you can wear, the BACtrack Skyn and ArborSense. We want to know how easy and comfortable these are for you to use every day. Your feedback will help us decide which device is better for future studies.